Verseon

4 articles about Verseon

• Verseon Pioneers New Way of Funding Innovation Through Security Token Offering

  3/18/2019

  Verseon is launching a security token offering aiming to set a new standard for the 21st century public offering to a globally connected investor base.

• Verseon Unveils New Transformative Blockchain Technology

  9/18/2018

  Blockchain initiative will enable medical and pharma companies to fund and accelerate life-saving developments 

• Verseon Unveils New Blockchain Technology

  9/18/2018

  Blockchain initiative will enable medical and pharma companies to fund and accelerate life-saving developments

• Verseon Commences Phase I Trial for Precision Oral Anticoagulant VE-1902

  9/13/2018

  Verseon today announces that it has received ethics committee approval and acknowledgement from the Therapeutic Goods Administration in Australia for the phase I clinical trial of VE-1902, the first clinical candidate from its novel class of precision oral anticoagulants (PROACs).